6 participants
Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-12-11
- Start Date:
- 2021-07-13
- Completion:
- 2024-02-20
Conditions
- Locally Advanced Undifferentiated Pleomorphic Sarcoma
- Metastatic Undifferentiated Pleomorphic Sarcoma
- Recurrent Undifferentiated Pleomorphic Sarcoma
- Unresectable Undifferentiated Pleomorphic Sarcoma
Interventions
- BIOLOGICAL